Sabatini Brent sold VIR
March 23, 2026 · Form 4 insider transaction
Sabatini Brent sold 7,711 shares of Vir Biotechnology, Inc. at $9.12 per share, a transaction worth $70.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
7,711
Price
$9.12
Total value
$70.3K
InsiderSabatini Brent
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 23, 2026
Filing dateMarch 24, 2026
Shares owned after61,902
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025.